Clinical Trial Phases

Clinical research unit prepared for an early-phase treatment study

Clinical Trial Phases Explainer

Clinical trial phases describe stages of studying a drug or certain other interventions in people. The phases are not grades of quality and do not apply identically to every kind of health research. For medicines, they generally move from early questions about dose and safety toward larger tests of effectiveness and broader safety, followed by studies after authorization or approval. A product can stop at any phase if evidence does not support continuing.

Phase 1 studies are usually small and focus on how an intervention behaves in humans, including dose, administration, and side effects. Phase 2 studies further evaluate safety and look for evidence that the treatment has the intended effect in people with the condition. Phase 3 studies are typically larger and compare the intervention with a standard treatment or control to confirm benefits, characterize risks, and provide evidence for regulatory decisions.

Phase 4 refers to study after marketing authorization or approval. It can examine less common harms, longer-term outcomes, real-world use, or additional questions. The boundaries are not always rigid: seamless or adaptive programs may combine objectives, and devices, behavioral interventions, or surgical procedures can follow different development pathways. A later phase does not mean the intervention is risk-free or guaranteed to work for every person.

Every phase still requires an appropriate protocol, ethical review, informed consent, monitoring, and honest reporting. The amount of prior evidence changes, as do the number and type of participants and the uncertainty they accept. Understanding the phase helps a potential participant ask what researchers already know, what the study is designed to learn, and how the risks differ from ordinary care.

Phase 1 emphasizes human safety, dose, administration, and how the body handles the intervention.

Phase 2 expands safety information and looks for evidence of the intended effect.

Phase 3 trials are often larger comparisons designed to confirm effectiveness and characterize important harms.

Their results can support regulatory and clinical decisions.

Phase 4 studies can examine longer-term use, uncommon harms, effectiveness in broader practice, or new questions.

Approval does not end evidence gathering.

Explore more "Explainers"

Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.